Patients
15.3 per 100,000 people
Suicide rate, South Africa, 2023 (WHO).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Vidhi Upadhyay
South Africa ADHD Drugs Market Industry Trends and Forecast to 2034: Segmented by (Drug Type, Age, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$129.1 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $141.2 Mn | — | — |
| 2025 (base) | $151.2 Mn | +$10.0 Mn | — |
| 2026 (forecast) | $161.9 Mn | +$10.7 Mn | +7.1% |
| 2027 (forecast) | $173.4 Mn | +$11.5 Mn | +14.7% |
| 2028 (forecast) | $185.7 Mn | +$12.3 Mn | +22.8% |
| 2029 (forecast) | $198.9 Mn | +$13.2 Mn | +31.6% |
| 2030 (forecast) | $213.0 Mn | +$14.1 Mn | +40.9% |
| 2031 (forecast) | $228.2 Mn | +$15.1 Mn | +50.9% |
| 2032 (forecast) | $244.4 Mn | +$16.2 Mn | +61.6% |
| 2033 (forecast) | $261.7 Mn | +$17.3 Mn | +73.1% |
| 2034 (forecast) | $280.3 Mn | +$18.6 Mn | +85.4% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $151.2 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $280.3 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Also called | Attention Deficit Hyperactivity Disorder (ADHD) Drugs |
| Segments | Drug type, age and end user (see all) |
| Key players | Takeda Pharmaceutical Company Ltd, Johnson & Johnson, Novartis AG, Supernus Pharmaceuticals, Teva Pharmaceutical (see all) |
| Regulator in South Africa | SAHPRASource: South African Health Products Regulatory Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
ADHD drugs treat attention deficit hyperactivity disorder in children and adults with stimulant and non-stimulant medicines.
Key segments of the ADHD Drugs market include drug type (Stimulants and Non-Stimulants) and age (Children, Adolescents and Adults).
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the ADHD Drugs market. Governments and employers are investing more in mental health care.
Digital tools, new drug classes and care built into primary care and workplaces give the ADHD Drugs market strong room to grow worldwide.
Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the ADHD Drugs market.
The ADHD Drugs market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The South African Health Products Regulatory Authority (SAHPRA) registers medicines.[1] Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone.[2] Suicide rate: 15.3 per 100,000 people in 2023, the latest WHO figure for South Africa.[3]
[1] South African Health Products Regulatory Authority. Checked 14 Nov 2026.
[2] National Department of Health. Checked 14 Nov 2026.
[3] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 20 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for ADHD Drugs. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in South Africa.
What doctors and scientists are doing in ADHD Drugs right now, from free public sources.
15.3 per 100,000 people
Suicide rate, South Africa, 2023 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 19 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.
From our blog
South Africa · 3 shared keywords
South Africa · 2 shared keywords
South Africa · 2 shared keywords
South Africa · 2 shared keywords
South Africa · 2 shared keywords
South Africa · 2 shared keywords
OTC & Nutraceuticals · South Africa
Public Health · South Africa
Digital Health · South Africa
Digital Health · South Africa
Public Health · South Africa
Public Health · South Africa